Development and validation of a multidimensional indicator-based risk prediction model for gestational diabetes mellitus: a nested case-control study

Gestational diabetes mellitus (GDM) could contribute to significant health risks in both mothers and their offspring. Therefore, this study aims to construct a prediction model to identify women at elevated risk for GDM in early pregnancy. Methods: This study was a nested case-control study. 346 participants were randomly allocated to the training set (n = 242) and the validation set (n = 104) at a ratio of 7:3. The least absolute shrinkage and selection operator (LASSO) regression was applied to select the most significant factors among candidate variables. A GDM risk prediction model was further established based on the risk factors chosen by the LASSO. The model’s calibration, discrimination, and clinical use were assessed using the calibration analysis, area under the receiver operating characteristic (ROC) curve and decision curve analysis (DCA). Finally, the model was presented with a nomogram. In the training set, a simple GDM risk prediction model was developed by using family history of diabetes, pre-pregnancy body mass index (BMI), progesterone, aspartate transaminase (AST), activated partial thromboplastin time (APTT), and triglyceride to high-density lipoprotein cholesterol (TG/HDL-C). Among them, family history of diabetes, higher pre-pregnancy BMI, progesterone, AST, and TG/HDL-C levels were associated with increased GDM risk, while higher APTT level was associated with decreased GDM risk. The calibration curve indicated satisfactory accuracy. The ROC curve demonstrated excellent discrimination, with the area under the curve (AUC) of 0.85 (95% confidence interval [CI], 0.80–0.91) and 0.73 (95%CI, 0.62–0.83) for the training and validation set, respectively. The DCA curve demonstrated high net benefit. Furthermore, internal validation with excellent performance demonstrated the generalizability of the model. The present study developed a model with excellent performance for predicting GDM. Furthermore, a nomogram was constructed to visualize the model. Therefore, this model can serve as an effective GDM prediction tool.

Authors

Institutions

Publication Details

Journal
BMC Endocrine Disorders
Published
2026-03-12
DOI
https://doi.org/10.1186/s12902-026-02227-9
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and validation of a multidimensional indicator-based risk prediction model for gestational diabetes mellitus: a nested case-control study

Linlin Hua, Xianqi Wang, Xia Zhang, Jiajia Chen et al.
BMC Endocrine Disorders
Gestational Diabetes Research and Management
article

Development and validation of a multidimensional indicator-based risk prediction model for gestational diabetes mellitus: a nested case-control study

Linlin Hua, Xianqi Wang, Xia Zhang, Jiajia Chen, Qing Zhang, Shanshan Yin, Guijuan Zhang, Shu Li, Xiao Hao, Shuling Wang, Ru Feng
article en

Abstract

Gestational diabetes mellitus (GDM) could contribute to significant health risks in both mothers and their offspring. Therefore, this study aims to construct a prediction model to identify women at elevated risk for GDM in early pregnancy. Methods: This study was a nested case-control study. 346 participants were randomly allocated to the training set (n = 242) and the validation set (n = 104) at a ratio of 7:3. The least absolute shrinkage and selection operator (LASSO) regression was applied to select the most significant factors among candidate variables. A GDM risk prediction model was further established based on the risk factors chosen by the LASSO. The model’s calibration, discrimination, and clinical use were assessed using the calibration analysis, area under the receiver operating characteristic (ROC) curve and decision curve analysis (DCA). Finally, the model was presented with a nomogram. In the training set, a simple GDM risk prediction model was developed by using family history of diabetes, pre-pregnancy body mass index (BMI), progesterone, aspartate transaminase (AST), activated partial thromboplastin time (APTT), and triglyceride to high-density lipoprotein cholesterol (TG/HDL-C). Among them, family history of diabetes, higher pre-pregnancy BMI, progesterone, AST, and TG/HDL-C levels were associated with increased GDM risk, while higher APTT level was associated with decreased GDM risk. The calibration curve indicated satisfactory accuracy. The ROC curve demonstrated excellent discrimination, with the area under the curve (AUC) of 0.85 (95% confidence interval [CI], 0.80–0.91) and 0.73 (95%CI, 0.62–0.83) for the training and validation set, respectively. The DCA curve demonstrated high net benefit. Furthermore, internal validation with excellent performance demonstrated the generalizability of the model. The present study developed a model with excellent performance for predicting GDM. Furthermore, a nomogram was constructed to visualize the model. Therefore, this model can serve as an effective GDM prediction tool.

BMC Endocrine Disorders
Henan Academy of Sciences (CN), Second Affiliated Hospital of Zhengzhou University (CN), Fifth Affiliated Hospital of Zhengzhou University (CN), Henan Provincial Health Bureau (CN)
Gender equality
Openalex Percentile: Top 22%
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.